DSLT Performance in Treatment-naïve Patients With Newly Diagnosed Open Angle Glaucoma

Barnet Dulaney Perkins Eye Centers55 enrolled

Overview

DSLT demonstrates a ≥ 20% reduction of IOP from pre-treatment baseline in POAG patients naïve of previous glaucoma treatment at 12 months.

DSLT enables newly diagnosed patients to remain well controlled and off medications

Study Type

OBSERVATIONAL

Enrollment

Conditions

Open Angle Glaucoma (OAG)

Interventions

DSLT enables newly diagnosed patients to remain well controlled and off medicationsDEVICE

DSLT enables newly diagnosed patients to remain well controlled and off medications

Eligibility

Sex: ALLMin age: 30 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Primary open angle glaucoma * Patients age 30 or greater with an IOP of 18-26 mmHg * Mild to moderate POAG patients (mild or moderate according to the AAO PPP Guidelines) * DSLT procedure Exclusion Criteria: * History of prior glaucoma treatment - this includes past medication use (in either eye), previous lasers or incisional surgery * Angle closure patients * Ocular Hypertension * Baseline VF MD of worse than -12dB * Uncontrolled systemic microvascular disease (eg. HTN, DM) * Subjects with peri-limbal findings (e.g. melanosis, tumors, extensive pterygium, significant senile arcus and pterygium)

Locations (1)

Barnet Dulaney Perkins Eye Centers

Mesa, Arizona, United States

RECRUITING

Outcomes

Primary Outcomes

Success of IOP Reduction Through DSLT Utilization

Proportion of patients (%) with DSLT success as defined as IOP lowering of \>20% and no additional medications or procedures at 12 months.

Time frame: 12 months